Known targets — ChEMBL curated mechanism
ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.87 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconic Acid SCHEMBL21082704 | 1.00 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL10799939 | 0.98 | LMNA (0.91) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL21082705 | 0.98 | LMNA (0.91) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL208644 | 0.98 | LMNA (0.91) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL25181488 | 0.95 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL19973172 | 0.95 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL16416518 | 0.95 | LMNA (0.95) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL23566696 | 0.95 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| SCHEMBL1884574 | 0.95 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL22983955 | 0.95 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213524-A1 | COMPOSITIONS FOR USE | AMAZENTIS SA (CH) | 2025-07-03 | — | — | US | claimed |
| WO-2025133367-A1 | UROLITHIN COMPOUNDS FOR ENHANCING OR IMPROVING FERTILITY | AMAZENTISSA (CH) | 2025-06-26 | — | — | WO | claimed |
| US-20210161941-A1 | Formulation for the Treatment of Polymorphisms in Methyl Metabolizing Genes and Methods of Treatment Thereof | BEN TRE GAY B (US) | 2021-06-03 | — | — | US | claimed |
| WO-2019147892-A1 | FORMULATION FOR THE TREATMENT OF POLYMORPHISMS IN METHYL METABOLIZING GENES AND METHODS OF TREATMENT THEREOF | BEN TRE GAY B (US) | 2019-08-01 | — | — | WO | claimed |
| US-20090018865-A1 | Earnest custom calibration system delivering dietary supplements | EARNEST CARMELLA LYNN | 2009-01-15 | — | — | US | claimed |
| EP-4710932-A1 | COMPOSITIONS COMPRISING MANGANESE FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE | Administración General de la Comunidad Autónoma de Euskadi (ES) | 2026-03-18 | — | — | EP | disclosed |
| US-20250213524-A1 | COMPOSITIONS FOR USE | AMAZENTIS SA (CH) | 2025-07-03 | — | — | US | disclosed |
| WO-2025133367-A1 | UROLITHIN COMPOUNDS FOR ENHANCING OR IMPROVING FERTILITY | AMAZENTISSA (CH) | 2025-06-26 | — | — | WO | disclosed |
| US-20250064096-A1 | MEAT-LIKE FOOD PRODUCTS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2025-02-27 | — | — | US | disclosed |
| US-12150464-B2 | Meat-like food products | BEYOND MEAT, INC. (US) | 2024-11-26 | — | — | US | disclosed |
| US-11849741-B2 | Meat-like food products | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-12-26 | — | — | US | disclosed |
| CN-108471779-B | Meat analog food product | 别样肉客公司 | 2022-07-26 | — | — | CN | disclosed |
| EP-2362725-B1 | Antiviral supplement formulations | VYMEDIC LLC (US) | 2015-01-07 | — | — | EP | disclosed |
| US-20090104320-A1 | Stabilization of Milk-Based Products | WILD FLAVORS INC. (US) | 2009-04-23 | — | — | US | disclosed |
| US-20060286207-A1 | STABILIZATION OF MALT-BASED AND HOPS-BASED PRODUCTS | WILD FLAVORS, INC. | 2006-12-21 | — | — | US | disclosed |
| US-20050129825-A1 | Stabilization of milk-based products | GRAY KIMBERLEY H (US) | 2005-06-16 | — | — | US | disclosed |
| EP-1425043-A1 | METHOD OF INCREASING THE PRESENCE OF GLUTATHIONE IN CELLS | N.V. Nutricia (NL) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003024487-A1 | METHOD OF INCREASING THE PRESENCE OF GLUTATHIONE IN CELLS | N.V. NUTRICIA (NL) | 2003-03-27 | — | — | WO | disclosed |
| US-6495170-B1 | PROPHYLAXIS OF LIVER DISORDERS BY ADMINISTERING PRODRUGS AND PROMOTERS OF GLUTATHIONE BIOSYNTHESIS, REGENERATION AND CONJUGATION | N. V. NUTRICIA (NL) | 2002-12-17 | — | — | US | disclosed |
| EP-0308983-A2 | NMR imaging with Mn(II) coordination compositions | SALUTAR, INC. (US) | 1989-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213524-A1 | COMPOSITIONS FOR USE | CYP17A1, ZYX, SHBG | LMNA 2467/4885PDE4A 1357/4885L3MBTL1 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.